Skip to main content
Smart Investors Daily
WR

NYSE · WRBY

Warby Parker Inc.

Healthcare · Medical - Instruments & Supplies

$21.94

Down-$0.65 (-2.96%)

Updated Nov 4, 2026, 9:17 PM

SID Score

3.5/10

Composite research score

Smart Money

58/100

Neutral

Market cap
3.69B
P/E ratio
5,164.61
Dividend yield
0.00%
52-week range
$14.96 – $31.00
Volume
4.38M
Avg. volume
2.66M

Price performance · WRBY

WRBY price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 3, 2026

WRBY closed at $21.94 after 21 trading sessions, down 16.36% for the selected period.

Last close
$21.94
Period change
-16.36%
Period low
$21.94
Period high
$26.52
Daily close
View OHLC price history
WRBY OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 3, 2026$23.85$23.89$21.585$21.944.38M
Nov 2, 2026$24.59$25.94$23.76$23.863.77M
Oct 30, 2026$24.96$25.02$23.835$24.612.93M
Oct 29, 2026$24.76$25.27$24.42$24.592.6M
Oct 28, 2026$24.89$25.38$24.20$24.432.09M
Oct 27, 2026$25.44$25.57$24.46$25.072M
Oct 26, 2026$26.20$26.48$25.00$25.282.14M
Oct 23, 2026$25.43$26.13$25.005$25.911.91M
Oct 22, 2026$25.49$26.62$25.02$25.672.52M
Oct 21, 2026$25.63$26.02$24.88$25.631.75M
Oct 20, 2026$25.10$25.95$25.02$25.622.85M
Oct 19, 2026$23.84$25.18$23.60$24.994.4M
Oct 16, 2026$24.61$25.11$23.33$23.342.79M
Oct 15, 2026$25.29$25.545$24.395$24.594.09M
Oct 14, 2026$26.38$26.39$24.46$24.923.07M
Oct 13, 2026$26.13$27.00$25.76$26.522.84M
Oct 12, 2026$24.92$26.31$24.755$25.992.16M
Oct 9, 2026$24.92$25.34$24.57$25.301.54M
Oct 8, 2026$25.05$25.32$24.16$24.952.83M
Oct 7, 2026$25.98$26.41$25.29$25.311.73M
Oct 6, 2026$26.89$26.89$25.90$26.233.26M

Latest WRBY news

The latest Smart Investors Daily articles mentioning WRBY.

WRBY research

Overview

Company profile and research snapshot.

Company profile

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$28.67
Implied upside
—
Analysts
—
WRBY recent ratings
DateFirmRatingTarget
Aug 7, 2026UBSNeutral—
Aug 7, 2026CitizensMarket Outperform—
Jun 29, 2026B of A SecuritiesBuy—
May 8, 2026UBSNeutral—
May 7, 2026BTIGBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 20, 2026

How Tecovas went from online-only to 50+ stores nationwide

Tecovas CEO David Lafitte joins host Elizabeth Gore to talk about how the "Warby Parker of cowboy boots" grew into a Western lifestyle brand with 50+ stores nationwide, and why “radical hospitality” is critical to the company’s success.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.